Topics

Fagron to Pay $22.5 Mln to Settle U.S. Allegations Over Inflated Drug Prices

17:06 EST 9 Nov 2019 | Medscape

Pharmaceutical supplier Fagron Holding USA LLC will pay $22.5 million to resolve allegations that its subsidiaries inflated average wholesale prices for compound drug ingredients and submitted fraudulent claims to federal healthcare programs, the U.S. Department of Justice said on Thursday.
Reuters Health Information

Original Article: Fagron to Pay $22.5 Mln to Settle U.S. Allegations Over Inflated Drug Prices

NEXT ARTICLE

More From BioPortfolio on "Fagron to Pay $22.5 Mln to Settle U.S. Allegations Over Inflated Drug Prices"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...